Ocular Rosacea microBiome Study (ORBS)—sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial

Trials

Study Protocol

Victoria Cavallino¹  Matilda Chan¹  Benjamin Arnold¹  Thuy Doan¹  Gerami D. Seitzman²  Jeremy D. Keenan²  John Gonzales²  Julie Schallhorn²  Thomas M. Lietman³  Hamidah Mahmud⁴ 

[1] Francis I. Proctor Foundation, University of California, San Francisco, CA, USA;Francis I. Proctor Foundation, University of California, San Francisco, CA, USA;Department of Ophthalmology, University of California, San Francisco, CA, USA;Francis I. Proctor Foundation, University of California, San Francisco, CA, USA;Department of Ophthalmology, University of California, San Francisco, CA, USA;Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA;San Francisco School of Medicine, University of California, San Francisco, CA, USA;Francis I. Proctor Foundation, University of California, San Francisco, CA, USA;

关键词: Ocular rosacea;    Microbiome;    Doxycycline;    Sub-microbial;    Antimicrobial resistance;   

DOI  :  10.1186/s13063-022-06948-9

 received in 2022-08-21, accepted in 2022-11-22,  发布年份 2022

来源: Springer

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

Fig. 2

12864_2022_9026_Article_IEq225.gif

Fig. 1

12951_2022_1749_Article_IEq8.gif